CN1267089C - 硫酸吗啡微粒,其制备方法及含有该物质的组合物 - Google Patents

硫酸吗啡微粒,其制备方法及含有该物质的组合物 Download PDF

Info

Publication number
CN1267089C
CN1267089C CNB008086052A CN00808605A CN1267089C CN 1267089 C CN1267089 C CN 1267089C CN B008086052 A CNB008086052 A CN B008086052A CN 00808605 A CN00808605 A CN 00808605A CN 1267089 C CN1267089 C CN 1267089C
Authority
CN
China
Prior art keywords
copolymer
microgranule
eudragit
neutral carrier
hydrophobic silica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB008086052A
Other languages
English (en)
Chinese (zh)
Other versions
CN1390121A (zh
Inventor
D·马里可
P·欧里
P·萨普里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EFFALM SA
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9546553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1267089(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Publication of CN1390121A publication Critical patent/CN1390121A/zh
Application granted granted Critical
Publication of CN1267089C publication Critical patent/CN1267089C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CNB008086052A 1999-06-09 2000-06-08 硫酸吗啡微粒,其制备方法及含有该物质的组合物 Expired - Lifetime CN1267089C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR99/07259 1999-06-09
FR9907259A FR2794646B1 (fr) 1999-06-09 1999-06-09 Microgranules de sulfate de morphine, procede de preparation et composition les contenant

Publications (2)

Publication Number Publication Date
CN1390121A CN1390121A (zh) 2003-01-08
CN1267089C true CN1267089C (zh) 2006-08-02

Family

ID=9546553

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB008086052A Expired - Lifetime CN1267089C (zh) 1999-06-09 2000-06-08 硫酸吗啡微粒,其制备方法及含有该物质的组合物

Country Status (24)

Country Link
US (2) US7063864B1 (enExample)
EP (3) EP1189602B1 (enExample)
JP (1) JP4296562B2 (enExample)
KR (1) KR100676123B1 (enExample)
CN (1) CN1267089C (enExample)
AR (2) AR024313A1 (enExample)
AT (2) ATE354356T1 (enExample)
AU (1) AU769160C (enExample)
BR (1) BRPI0011404B8 (enExample)
CA (1) CA2376339C (enExample)
CO (1) CO5160317A1 (enExample)
CY (1) CY1107612T1 (enExample)
DE (1) DE60033519T2 (enExample)
DK (2) DK1189602T3 (enExample)
ES (2) ES2280226T3 (enExample)
FR (1) FR2794646B1 (enExample)
HK (1) HK1045107B (enExample)
MX (1) MXPA01012751A (enExample)
NZ (1) NZ516077A (enExample)
PT (2) PT1627631E (enExample)
SI (1) SI1189602T1 (enExample)
TW (1) TWI224510B (enExample)
WO (1) WO2000074659A1 (enExample)
ZA (1) ZA200110087B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
JP4848101B2 (ja) * 2001-08-17 2011-12-28 株式会社フジモト・コーポレーション 徐放性マイクロペレット
EP1429739A1 (en) 2001-09-21 2004-06-23 Egalet A/S Polymer release system
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
DE602004031096D1 (de) 2003-03-26 2011-03-03 Egalet As Morphin-system mit kontrollierter freisetzung
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
CA2687192C (en) 2007-06-04 2015-11-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
US20190038769A1 (en) * 2010-12-01 2019-02-07 Gowey Research Group, Pllc Micro-rna profiling, compositions, and methods of treating diseases
JP2012250926A (ja) * 2011-06-01 2012-12-20 Nitto Denko Corp 粒子製剤
US9549899B2 (en) 2012-07-06 2017-01-24 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
IL273627B2 (en) 2017-12-20 2025-03-01 Purdue Pharma Lp Morphine sulfate dosage forms for abuse deterrence

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514665D0 (en) 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
CA2007181C (en) 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
GB9119958D0 (en) 1991-09-18 1991-10-30 Unilever Plc Detergent compositions
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
SE9301057L (sv) 1993-03-30 1994-10-01 Pharmacia Ab Beredning med kontrollerad frisättning
HU218673B (hu) * 1993-10-07 2000-10-28 Euroceltique S.A. Opioid analgetikumot tartalmazó elnyújtott hatóanyag-felszabadítású orális gyógyszerkészítmény és eljárás előállítására
US5411745A (en) 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
US5460826A (en) 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
FR2771291B1 (fr) * 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant

Also Published As

Publication number Publication date
US20070003620A1 (en) 2007-01-04
FR2794646A1 (fr) 2000-12-15
AU769160C (en) 2006-02-23
KR20020031338A (ko) 2002-05-01
CN1390121A (zh) 2003-01-08
MXPA01012751A (es) 2002-07-02
EP1627631A2 (fr) 2006-02-22
DE60033519T2 (de) 2007-10-31
WO2000074659A1 (fr) 2000-12-14
CO5160317A1 (es) 2002-05-30
AR024313A1 (es) 2002-09-25
AR068015A2 (es) 2009-10-28
HK1045107A1 (en) 2002-11-15
ATE544448T1 (de) 2012-02-15
BR0011404A (pt) 2002-03-05
JP2003520770A (ja) 2003-07-08
TWI224510B (en) 2004-12-01
KR100676123B1 (ko) 2007-01-31
EP1189602B1 (fr) 2007-02-21
DK1189602T3 (da) 2007-07-02
BR0011404B1 (pt) 2013-03-05
CY1107612T1 (el) 2013-03-13
EP1627631B1 (fr) 2012-02-08
HK1045107B (zh) 2007-05-11
ES2379688T3 (es) 2012-04-30
DE60033519D1 (de) 2007-04-05
DK1627631T3 (da) 2012-04-30
AU5539400A (en) 2000-12-28
US7063864B1 (en) 2006-06-20
EP1189602A1 (fr) 2002-03-27
ZA200110087B (en) 2003-03-03
ES2280226T3 (es) 2007-09-16
EP1818051A1 (fr) 2007-08-15
BRPI0011404B8 (pt) 2021-05-25
AU769160B2 (en) 2004-01-15
CA2376339A1 (fr) 2000-12-14
CA2376339C (fr) 2011-05-17
PT1189602E (pt) 2007-05-31
ATE354356T1 (de) 2007-03-15
FR2794646B1 (fr) 2001-09-21
NZ516077A (en) 2004-06-25
JP4296562B2 (ja) 2009-07-15
SI1189602T1 (sl) 2007-06-30
EP1627631A3 (fr) 2006-03-15
PT1627631E (pt) 2012-05-21

Similar Documents

Publication Publication Date Title
CN1025283C (zh) 生产控制释放产品时用的小珠的制备方法
CN1292742C (zh) 阿片类药物延缓控释制剂
CN1023293C (zh) 一种含有美多心安盐的控制释放制剂的制备方法
CN1201732C (zh) 缓释的口服药物形式
CN1169522C (zh) 新颖的控释珠粒、其制备方法和包含它的多单位制剂
CN1051225C (zh) 稳定的胃酸耐受奥美拉唑微粒组合物及其制备方法
CN1104891C (zh) 缓释制剂
CN1114405C (zh) 胃保护性奥美拉唑微粒、其制备方法及药物制剂
CN1267089C (zh) 硫酸吗啡微粒,其制备方法及含有该物质的组合物
CN1220485C (zh) 制备遮味的且活性物质即释的包衣颗粒的方法
CN1035099C (zh) 持效性制剂的制备方法
CN1893929A (zh) 缓释文拉法辛药物制剂
CN87107792A (zh) 包衣膜及由它制备的组合物
CN1638771A (zh) 3－[(2－{[4－(己氧羰基氨基－亚氨基－甲基)－苯基氨基]－甲基}－1－甲基－1h－苯并咪唑－5－羰基）－吡啶－2－基－氨基]－丙酸乙酯及其盐的口服施用的投药剂型
CN110664780B (zh) 延迟释放型半胱胺珠粒调配物，以及其制备及使用方法
CN1154482C (zh) 粒状结晶布洛芬的包衣颗粒
CN1747723A (zh) 含活性成分混合物的组合物及其制备方法
CN1135981C (zh) 硫酸吗啡微粒、其制备方法和药物制剂
CN1081029C (zh) 丙戊酸金属盐缓释片剂
CN1161112C (zh) 含氯雷他定和伪麻黄碱的药物胶囊组合物
CN1186014C (zh) 程序化和随时间释放的多颗粒药物剂型及其制备方法
CN1525852A (zh) 被掩味的包衣颗粒和粒状物
CN1842331A (zh) 含有氨磺必利的新颖固体药物组合物
CN1893927A (zh) 抗生素组合物
CN1207681A (zh) 含硫氮䓬酮活性成分的缓释微粒

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: ETHYPHARM COMPANY

Free format text: FORMER NAME OR ADDRESS: ROOM #, AIDIKEAIDIFAMUYAOPINSHIYAN

CP01 Change in the name or title of a patent holder

Address after: Wudang, France

Patentee after: Effalm S.A.

Address before: Wudang, France

Patentee before: Labortoires Des Produits Ethiques Ethypharm

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20060802